EE247 Emicizumab is Cost-Saving for Finnish Hemophilia A Patients with Factor VIII Inhibitors
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.514
https://www.valueinhealthjournal.com/article/S1098-3015(23)03644-6/fulltext
Title :
EE247 Emicizumab is Cost-Saving for Finnish Hemophilia A Patients with Factor VIII Inhibitors
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03644-6&doi=10.1016/j.jval.2023.09.514
First page :
Section Title :
Open access? :
No
Section Order :
12534